期刊文献+

山西省闻喜县艾滋病患者抗病毒治疗的毒副反应 被引量:11

Adverse effects of antiretroviral treatment among AIDS patients in Wenxi,Shanxi
原文传递
导出
摘要 目的了解山西省农村地区艾滋病患者接受国家免费抗逆转录病毒治疗(ART)后毒副反应发生情况并分析其影响因素。方法对山西省闻喜县2004年7月1日至2009年12月1日纳入免费ART项目的 205例艾滋病患者进行研究,所有患者定期进行毒副反应临床和实验室评估。采用SPSS11.5软件进行统计分析,率的比较采用χ2检验,P<0.05为差异有统计学意义。结果患者中位治疗时间为47.0个月。在治疗过程中,84.6%的患者出现药物相关毒副反应,常见的短期毒副反应有消化系统症状(52.8%)、贫血(38.5%)、疲倦(30.3%)、皮疹(24.1%)和中枢神经系统症状(16.4%)等;中长期毒副反应有肝毒性(17.4%)、外周神经炎(15.9%)和血清淀粉酶升高(9.2%)等。ddI与消化系统症状,AZT与贫血,d4T、ddI和AZT与外周神经炎,NVP和EFV与皮疹和肝毒性,NVP与中枢神经系统毒性以及d4T与血清淀粉酶升高间有一定的特异关联。针对NVP诱导的肝毒性和AZT诱导的贫血,在更换药物后,患者血液生化指标均恢复正常。结论抗病毒治疗开始后短期与长期内有不同的毒副反应谱,且有一定药物特异性,应保持对患者治疗不同阶段常见药物毒副反应的定期监测,及时采取相应措施。 Objective To determine the prevalence of adverse effects of antiretroviral treatment regimens among free treated rural AIDS patients in Shanxi province.Methods We observed the adverse events of 205 rural AIDS patients,who received Chinese Central Government sponsored free antiretroviral treatment(ART) between July 1st,2004 and December 1st,2009.The observations of adverse effects included clinical evaluation and laboratory testing.Results The adverse events of ART occurred in 84.6% of AIDS patients with either clinical or laboratory evaluation.Commonly occurred short-term adverse events included gastrointestinal toxicities(52.8%),anemia(38.5%),fatigue(30.3%),rash(24.1%) and central nervous system(CNS) toxicity(16.4%),and long-term adverse effects included hepatotoxicity(17.4%),peripheral neurotoxicity(15.9%) and evaluated serum amylase(9.2%),respectively.Anemia was most frequently observed with AZT treatment;gastrointestinal toxicities with ddI;peripheral neurotoxicity with d4T,ddI and AZT;hepatotoxicity and rash with NVP and EFV;CNS toxicity with NVP and elevated serum amylase with d4T.The symptoms of liver toxicity and anemia could be reduced with alternative treatment with NVP and AZT.Conclusion The short and long term adverse events are common among ART AIDS patients.Some symptoms were frequently observed in certain drugs.Regular surveillance and adverse event treatment are essential for successful AIDS patient ART treatment.
出处 《中国预防医学杂志》 CAS 2010年第12期1189-1193,共5页 Chinese Preventive Medicine
基金 国家自然科学基金(30671880) 上海市重点学科建设项目(B118)
关键词 艾滋病患者 抗病毒治疗 毒副反应 AIDS patients Antiretroviral treatment Adverse effects Adverse events
  • 相关文献

参考文献14

  • 1Egger M, May M, Chene G, et al. Prognosis of HIV-1 infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies [J]. Lancet, 2002, 360 (9327) 119-129. 被引量:1
  • 2姚璇,詹发先,彭国平.湖北省艾滋病抗病毒治疗终止原因分析[J].中国艾滋病性病,2006,12(6):495-497. 被引量:27
  • 3Montessori V, Press N, Harris M, et al. Adverse effects of antiretroviral therapy for HIV infection [J]. CMAJ, 2004, 170 (2) : 229-238. 被引量:1
  • 4中国疾病预防控制中心性病艾滋病预防控制中心.国家免费艾滋病抗病毒药物治疗手册[M].北京:人民卫生出版社,2005. 被引量:3
  • 5Ira Shah. Adverse effects of antiretroviral therapy in HIV-1 infected children [J].J Trop Pediatr, 2006, 52 (4): 244-248. 被引量:1
  • 6Hawkins T. Understanding and managing the adverse effects of antiretroviral therapy [J]. Antiviral Res, 2010, 85 (1): 201- 209. 被引量:1
  • 7周伟,危剑安,孙利民,黄霞珍,陈宇霞,宋春鑫.AIDS的高效抗逆转录病毒疗法的毒副作用[J].中国艾滋病性病,2005,11(1):73-75. 被引量:31
  • 8Wong KH, Chan KC, Lee SS. Sex differences in nevirapine rash [J].Clin Infect Dis, 2001, 32 (1): 124-129. 被引量:1
  • 9George C, Yesoda A, Jayakumar B, Lal L. A prospective study evaluating clinical outames and costs of three NNRTI- based HAART regimens in kerala, ludia [J].J Clin Pharm Ther, 2009, 34 (1) 33-40. 被引量:1
  • 10den Brinker M, Wit FW, Wertheim-van Dillen PM, et al. Hepatitis B and C virus co-infection and the risk for hepatotoxieity of highly active antiretroviral therapy in HIV-1 infection [J]. AIDS, 2000, 14 (18): 2895-2902. 被引量:1

二级参考文献18

  • 1Jennifer PAN.Current progress of China’s free ART program[J].Cell Research,2005,15(11):877-882. 被引量:40
  • 2Corzo JE,Gomez-Mateos J,Rueda A.Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients[J].HIV Clin Trials,2003,4(5):337-346. 被引量:1
  • 3Shah SS,Rodriguez T,McGowan JP.Miller Fisher variant of Guillain-Barre syndrome associated with lactic acidosis and stavudine therapy.Clin Infect Dis[J].2003,36(10):131-133. 被引量:1
  • 4Montaner IS,Cote HC,Harris M.Mitochnodrial toxicity in the era of HA ART:evaluating venous lactate and peripheral blood mitochnodrial DNA in HIV-infected patients taking antiretr oviral therapy[J].J Acquir Immune Defic Syndr,2003,34 Suppl(1):S85-90. 被引量:1
  • 5Gerard Y,Viget N,Yazdanpanah Y.Hyperlactataemia during antiretrovir al therapy:incidences,clinical data and treatment[J].Therapie,2003,58(2):153-158. 被引量:1
  • 6Kontorinis N,Dieterich DT.Toxicity of non-nucleoside analogue reve rse transcriptase inhibitors[J].Semin Li ver Dis,2003,23(2):173-182. 被引量:1
  • 7Rhew DC,Bernal M,Aguilar D,et al.Association between protease in hibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus:a system atic review[J].Clin Infect Dis,2003,37(7):959-972. 被引量:1
  • 8Penzak SR,Chuck SK.Scand J Infect Dis,2000,32(2):111-123. 被引量:1
  • 9Graham NM.J Acquir Immune Defic Syndr,2000:25 (Suppl 1):S4-11. 被引量:1
  • 10McComsey G,Maa JF.Host factors maybe more important than choice of antiretrovirals in the development of lipoatrophy[J].AIDS Read,2003,13(11):539-542,559. 被引量:1

共引文献56

同被引文献100

引证文献11

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部